Why do hospital purchase contracts require 503B-specific insurance?

Hospital purchase contracts treat 503B outsourcing facilities as FDA-registered drug manufacturers (which they technically are), not as pharmacies. The insurance schedule attached to hospital purchase contracts reflects that posture: it demands products liability towers with additional-insured wording, primary and non-contributory provisions, waiver of subrogation, 30-day notice of cancellation, and FDA recall extensions that the standard 503A pharmacy insurance program does not provide.

The schedule is enforced through automated credentialing platforms (Symplr, Reptrax, Vendormate, OptumRx supplier portals) which block hospital purchases when COIs do not match line by line. A 503B that satisfied the hospital schedule at initial onboarding but lets the program drift can find purchasing blocked within days.

The right insurance architecture for a 503B serving hospital systems sits closer to a CDMO insurance program than to a community pharmacy program: $5M-$10M products liability, hospital additional-insured endorsements, dedicated recall coverage ($1M-$10M), cGMP property with validation extension, plus druggist professional liability layered on top.